CSR Corporation Limited

GF Securities Sponsors the HKUST Entrepreneurship Competition for the 7th Consecutive Year To Help Nurture Young Entrepreneurs in Hong Kong

Retrieved on: 
星期五, 六月 16, 2023
Therapy, Investment, Heart, University, Platinum, Reward, The Hong Kong University of Science and Technology, Attention, CSR Corporation Limited, Competition, MIT $100K Entrepreneurship Competition, Bottom, GF Securities, Student, MAI, Entrepreneurship, Dream, Artificial intelligence, Growth, ESG, GF, Management, Creative industries

Ms. Xiaoying MAI, Executive Director of GF Investments (Hong Kong) Co., Ltd. (first left), presented the "GF Innovation Award" to Allegrow

Key Points: 
  • Ms. Xiaoying MAI, Executive Director of GF Investments (Hong Kong) Co., Ltd. (first left), presented the "GF Innovation Award" to Allegrow
    Mr. Xiaodong LIN, CEO of GF Holdings (Hong Kong) Corporation Limited, also paid close attention on the entrepreneurship competition and encouraged the participating teams.
  • GF Holdings (Hong Kong) is dedicated to entrepreneurial spirit through this kind of competition to invest in the future."
  • As the platinum sponsor of the competition for 7 consecutive years, GF Securities has been fully supporting innovation and entrepreneurship of youths.
  • As the offshore investment arm of GF Securities, GF Investments (Hong Kong) has always paid close attention to outstanding start-ups in various fields.

Antengene Announces Upcoming Presentations at the 2022 Society for Immunotherapy of Cancer Annual Meeting

Retrieved on: 
星期六, 十月 8, 2022
Hong Kong Stock Exchange, Therapy, IND, NDA, Annual report, Company, CSR Corporation Limited, NDAS, Greater, SEHK, Genta (company), Patient, Risk, Pharmaceutical industry

Since 2017, Antengene has built a broad and expanding pipeline of 15 clinical and preclinical assets, of which 10 are global rights assets, and 5 came with rights for Asia Pacific markets including the Greater China region.

Key Points: 
  • Since 2017, Antengene has built a broad and expanding pipeline of 15 clinical and preclinical assets, of which 10 are global rights assets, and 5 came with rights for Asia Pacific markets including the Greater China region.
  • The forward-looking statements made in this article relate only to the events or information as of the date on which the statements are made in this article.
  • You should read this article completely and with the understanding that our actual future results or performance may be materially different from what we expect.
  • In this article, statements of, or references to, our intentions or those of any of our Directors or our Company are made as of the date of this article.

In Full Support of the Entrepreneurship of Hong Kong Youths, GF Securities Sponsors the HKUST Entrepreneurship Competition for the 6th Consecutive Year

Retrieved on: 
星期三, 七月 6, 2022
Knowledge, Patient, Renewable energy, CSR Corporation Limited, Heart, GF, Platinum, University, Research, Poverty, E Fund Management (Hong Kong) Co., Limited, Dream, Investment, Student, Left, Seemabaddha, Entrepreneurship, Company, Tsinghua University, Peking University, Country, Shenzhen Stock Exchange, Private equity, Bottom, Technology, Yangtze Delta, Social responsibility, Risk management, City, Social, Education, Creative industries, Security (finance)

HONG KONG, July 6, 2022 - (ACN Newswire) - The HKUST-Sino One-Million-Dollar Entrepreneurship 2022 Competition, sponsored by GF Securities Co., Ltd. ("GF Securities", stock code: 1776.HK; 000776.SZ) for the 6th consecutive year, has come to a successful end.

Key Points: 
  • HONG KONG, July 6, 2022 - (ACN Newswire) - The HKUST-Sino One-Million-Dollar Entrepreneurship 2022 Competition, sponsored by GF Securities Co., Ltd. ("GF Securities", stock code: 1776.HK; 000776.SZ) for the 6th consecutive year, has come to a successful end.
  • The competition this year covers other regions including Macau, Beijing, Foshan, Guangzhou, Shenzhen, and the Yangtze River Delta.
  • This year's competition in Hong Kong consisted of four rounds, attracting the participation of 175 teams.
  • As the long-term sponsor of the competition, GF Securities proactively participated in the competition progress and was invited to the prize giving ceremony as one of the award presenters.

Antengene to Participate in Three Upcoming Investor Conferences in May/June

Retrieved on: 
星期五, 五月 6, 2022
Greater, NDAS, IND, Border, Company, NDA, Drug discovery, Patient, Genta (company), Cancer, Risk, Annual report, CSR Corporation Limited, Hong Kong Stock Exchange, SEHK, Pharmaceutical industry, Security (finance)

SHANGHAI and HONG KONG, May 5, 2022 /PRNewswire/ -- Antengene Corporation Limited ("Antengene" SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class therapeutics in hematology and oncology, today announced that the Company will be participating virtually in three upcoming investor conferences.

Key Points: 
  • Antengene Corporation Limited ("Antengene", SEHK: 6996.HK) is a leading commercial-stage R&D-driven global biopharmaceutical company focused on innovative first-in-class/best-in-class therapeutic medicines for cancer and other life-threatening diseases.
  • Driven by its vision of "Treating Patients Beyond Borders", Antengene aims to provide the most advanced anti-cancer drugs to patients in the Asia Pacific Region and around the world.
  • Leveraging partnerships as well as in-house drug discovery, Antengene has built a broad and expanding pipeline of 15 clinical and pre-clinical assets.
  • Antengene has global rights on 10 programs and Asia Pacific rights, including the Greater China region, on 5 programs.